General Information of Drug (ID:
DR1140) |
Drug Name |
RWJ-241947
|
Synonyms |
Isaglitazone; MCC 555; MCC-555; MCC555; Netoglitazone; Netoglitazone (USAN/INN); Netoglitazone [USAN:INN]; PGX-510; PKWDZWYVIHVNKS-UHFFFAOYSA-N; RWJ-241947; SCHEMBL142658; SYN5111; 161600-01-7; 5-((6-((2-Fluorobenzyl)oxy)naphthalen-2-yl)methyl)thiazolidine-2,4-dione; 5-({6-[(2-fluorobenzyl)oxy]naphthalen-2-yl}methyl)-1,3-thiazolidine-2,4-dione; 5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]-1,3-thiazolidine-2,4-dione; AC1L4BXM; AOB1631; API0009623; C21H16FNO3S; CHEMBL93747; DB09199; DTXSID5043712; GTPL2707; MLS006010812
|
Indication |
Fatty liver disease
[ICD11: DB92]
|
Phase 2
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
381.4 |
Topological Polar Surface Area |
80.7 |
Heavy Atom Count |
27 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
1 |
Hydrogen Bond Acceptor Count |
5 |
Cross-matching ID |
- PubChem CID
- 204109
- PubChem SID
-
10266079
; 12014903
; 14804654
; 30409351
; 47206874
; 53789988
; 56314529
; 57399414
; 78102491
; 103302827
; 104438295
; 126455542
; 127315825
; 127315826
; 127315827
; 127315828
; 127315829
; 127334948
; 127334949
; 127334950
; 127334951
; 127334952
; 134224278
; 134339349
; 134339958
; 135178649
; 135650709
; 137063230
; 140097400
; 143170090
; 162222887
; 176225523
; 179150029
; 215780839
; 223704978
; 223908693
; 226509499
; 252450244
; 252543600
- CAS Number
-
- TTD Drug ID
- D02TGD
- Formula
- C21H16FNO3S
- Canonical SMILES
- C1=CC=C(C(=C1)COC2=CC3=C(C=C2)C=C(C=C3)CC4C(=O)NC(=O)S4)F
- InChI
- 1S/C21H16FNO3S/c22-18-4-2-1-3-16(18)12-26-17-8-7-14-9-13(5-6-15(14)11-17)10-19-20(24)23-21(25)27-19/h1-9,11,19H,10,12H2,(H,23,24,25)
- InChIKey
- PKWDZWYVIHVNKS-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.